<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 336 consecutive patients attending a university-affiliated memory unit, clinical and psychological findings, neuroimaging and laboratory tests were analyzed </plain></SENT>
<SENT sid="1" pm="."><plain>The patients were diagnosed with early <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> 3%, senile <z:hpo ids='HP_0000726'>dementia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>) 16%, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VAD) 20%, other <z:hpo ids='HP_0000726'>dementias</z:hpo> 9%, minor <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (dysmentia) 32% and subjective symptoms only 21% </plain></SENT>
<SENT sid="2" pm="."><plain>Increases in vascular risk factors, serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, ApoE4 load and neuroimaging pathology were found in <z:hpo ids='HP_0000726'>dementia</z:hpo> but also in dysmentia and in patients with subjective symptoms only </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels correlated inversely with cognitive performance </plain></SENT>
<SENT sid="4" pm="."><plain>The increases in serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, which were pathological in VAD, Dysmentia and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>, may be indicative of a disturbed cerebral one-carbon metabolism and signal-accelerated development of <z:e sem="disease" ids="C0009241" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive disease</z:e> </plain></SENT>
</text></document>